Celsius Q3 sales expected to drop 12%, recovery doubts remain, says Jefferies

Celsius Holdings is projected to report a 12% decline in third-quarter sales, with Jefferies highlighting ongoing concerns about the brand's recovery. While the quarter may represent a low point, the focus shifts to when growth will resume and accelerate as the company completes its product cleanup. Jefferies forecasts Q3 sales of $803 million and adjusted EBITDA of $164 million, slightly below expectations, and notes a decline in market share and household penetration due to product cuts and paused innovation. The bank expects improvement in Q4 results with new product launches and easier comparisons but warns that stronger retail competition could limit recovery. The 2027 innovation pipeline is seen as a key opportunity to rebuild consumer interest and return to growth, with Jefferies valuing Celsius at $42 per share based on 2028 EBITDA estimates.

Celsius Holdings shares are trading at USD 27.19 on Pluang as of Oct 07, 2026 01:42 WIB, down 1.20% in the last day. The stock's market cap stands at $6.96 billion, reflecting investor caution amid the reported sales decline. Despite the current challenges, all Pluang order activity is on the buy side, indicating some investor interest in the stock.